Introduction {#s1}
============

How reactive oxygen species (ROS) affect aging is a fundamental issue in biology ([@bib4]; [@bib47]; [@bib30]; [@bib72]; [@bib70]; [@bib41]; [@bib69]; [@bib16]; [@bib6]; [@bib60]; [@bib88]; [@bib87]). Chronic exposure to ROS leads to cellular damage and age-associated diseases, including Alzheimer's disease, Parkinson's disease, cancer, diabetes, cardiovascular diseases, and chronic inflammation. By contrast, low or acute ROS exposure mobilizes protective mechanisms and increases lifespan in *S. cerevisiae* ([@bib68]; [@bib61]; [@bib82]), *D. melanogaster* ([@bib1]), *C. elegans* ([@bib84]; [@bib15]; [@bib100]; [@bib81]; [@bib52]), and rodents ([@bib50]; [@bib54]), and has been associated with health benefits in humans ([@bib71], [@bib72]). This phenomenon is conceptualized as mitochondrial hormesis or mitohormesis ([@bib70]).

Hormesis is defined as the induction of protective mechanisms under exposure to low doses of stressful agents, which at higher or prolonged exposures are harmful. Ninety percent of cellular ROS arise as a by-product of mitochondrial oxidative phosphorylation ([@bib28]). Moderate mitochondrial dysfunction leads to elevation of mitochondrial-derived ROS, activating protective mechanisms (mitohormesis) and promoting longevity ([@bib70]). Several longevity interventions, such as dietary restriction or reduced insulin/IGF-1 signaling, are associated with an increase in mitochondrial ROS levels, which acts as a retrograde signal to increase lifespan ([@bib84]; [@bib97]; [@bib104]).

One mechanism by which ROS affect cellular signaling is by specifically and reversibly reducing/oxidizing reactive thiol-groups on cysteine residues, thereby modifying protein functions, which is also known as redox signaling. For instance, ROS promote receptor tyrosine kinase (RTK) signaling by oxidizing a cysteine residue in protein-tyrosine phosphatase 1 (PTP1), thereby transiently inactivating its phosphatase activity ([@bib77]; [@bib26]) and potentiating the activity of its partner RTK. Localized ROS that act as signals do so at short range (\~5--20 µm; \[[@bib98]\]) with a half-life of \~1 ms ([@bib14]), in part due to high intracellular concentration of the antioxidant glutathione (1--10 mM; \[[@bib59]\]), which keeps the cytosol in a reduced environment ([@bib23]; [@bib74]; [@bib49]). Hence, pools of localized ROS must be rapidly generated for redox signaling to occur.

In addition to ROS derived as a by-product of mitochondrial oxidative phosphorylation, cells have membrane-associated enzymes that generate ROS, using nicotinamide adenine dinucleotide phosphate (NADPH) as an electron donor to produce a local ROS micro-environment ([@bib7]). In general, NADPH oxidases form complexes with subunits required for their stability and activation ([@bib7]). For instance, upon stimulation of cell surface receptors, guanosine-trisphospate (GTP) bound Rho-guanosine-triphosphatase (GTPase) family members and p21-activated kinase-1 (PAK1) must be recruited to the NADPH oxidase complex to generate ROS ([@bib38]).

Mammals have seven NADPH oxidase family members, which have been found in almost every tissue and are localized at cellular membranes and within intracellular compartments, such as endosomes and endoplasmic reticulum (ER) ([@bib7]; [@bib47]). Mammalian NADPH oxidases have been implicated in a wide range of normal physiological functions, ([@bib7]; [@bib47]), as well as in diseases that include cancer ([@bib94]).

NADPH oxidase-generated ROS have been shown to act as a second messenger to regulate migration of metastasis-committed-cancer cells and as a chemoattractant for immune cells during wound healing ([@bib91]; [@bib38]). Mediator of ErbB2 driven cell motility (Memo1) has been shown to play an important role in migration of breast cancer cells and is needed for robust metastatic dissemination from primary tumors to lungs ([@bib56]; [@bib55]). During the migratory process Memo1 interacts with Rho GTPase to dynamically reorganize actin and microtubule fibers ([@bib103]), and has also been linked to NADPH oxidase activity in breast cancer cells ([@bib55]). However, whether NADPH oxidase generated ROS have a biological function during aging is unknown. Here, we used the model organism *Caenorhabditis elegans* to investigate the role of NADPH oxidase generated ROS in aging. The nematode *C. elegans* provides the advantages of genetic tractability, and of being transparent that allows *in vivo* non-invasive visualization of transgenic fluorescent probes that measure ROS levels ([@bib5]). Moreover, *C. elegans* has a short lifespan, making it ideal to gain mechanistic insights into the aging process. We found that loss of the *C. elegans memo-1/C37C3.8* leads to elevated ROS levels generated by BLI-3/NADPH oxidase, which activates an adaptive detoxification system regulated by the transcription factor SKN-1/Nrf1,2,3 in promoting organismal-wide oxidative stress resistance and longevity.

Results {#s2}
=======

Loss of *memo-1* increases lifespan and oxidative stress resistance {#s2-1}
-------------------------------------------------------------------

The nematode *C. elegans* encodes a gene (C37C3.8) that shares 153 out of 297 amino acids (52%) identity with human Memo1 ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), which we named *memo-1* (Mediator of ErbB2-driven cell motility-like protein; wormbase.org). The *C. elegans memo-1* gene product is expressed in the embryo and larval stages and through adulthood in many neuronal and non-neuronal cells in the head and tail, spermatheca, distal tip cells, anchor cell, and intestine (*jxEx8* \[P*memo-1*::GFP\] and *ldEx112* \[MEMOfosmid::GFP\]; [Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B--I](#fig1s1){ref-type="fig"}). To gain insight into the biological function of *memo-1* in *C. elegans*, we took a reverse genetics approach using *memo-1* RNA interference (*memo-1(RNAi)*) or *memo-1(gk345)* putative null mutants (*memo-1(-)*; [Figure 1B](#fig1){ref-type="fig"}) and measured longevity. Both *memo-1(RNAi)*) and *memo-1(gk345)* mutants showed a 7--38% increase in lifespan compared to wild type ([Figure 1C](#fig1){ref-type="fig"}, [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). We also tested these mutants for several pathways related to Memo1 activities in vertebrates ([@bib90]; [@bib56]), which include phenotypes linked to the epidermal growth factor receptor (EGFR) and insulin/IGF-1 receptors ([Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}), and to cell migration ([Figure 1---figure supplement 2F--J](#fig1s2){ref-type="fig"}). We found that *memo-1(-)* mutants behaved like the wild-type strain. To exclude any developmental effects of *memo-1* loss, we treated wild-type animals with *memo-1(RNAi)* starting from the first day of adulthood and showed that this was sufficient to increase lifespan ([Figure 1D](#fig1){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}).10.7554/eLife.19493.002Figure 1.Loss of *memo-1* leads to increased ROS.(**A**) Transcriptional fusion of the *memo-1* promoter (P*memo-1*) with GFP (*jxEx8* \[P*memo-1*::GFP\]) shows that *memo-1* is expressed in neurons, pharyngeal cells, and intestine in adult *C. elegans*. Anterior to the left, ventral side down. Scale bar = 100 µm. (**B**) Genomic organization of the *C37C3.8 (memo-1)* locus (gray is untranslated UTR; black are translated exons; adapted from wormbase.org). The *memo-1* gene encodes two isoforms (C37C3.8a and C37C3.8b), whereby C37C3.8b is predicted to be 48 amino acids longer than C37C3.8a (297 amino acids). The *gk345* allele (red) is a 915 bp deletion. RNAi\#1 clone (purple) and RNAi\#2 clone (orange) are from Vidal- and Ahringer RNAi libraries, respectively. See Materials and methods for more details. (**C**) *memo-1(gk345)* mutants show a 27% increase in mean lifespan compared to wild type (N2) at 20°C. *P* value determined by log-rank. Statistics and additional lifespan data are in [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**D**) Knockdown of *memo-1(RNAi\#1)* starting on the first day of adulthood in RNAi-sensitive animals (*rrf-3(pk1426)*) increases mean lifespan by 20% compared to empty RNAi vector control (L4440) at 20°C. *P* value determined by log-rank. Statistics and additional lifespan data are in [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**E**) *memo-1(RNAi\#2)* treated wild type (N2) (-) have higher mRNA expression levels of the oxidative stress response genes, such as glutamine cysteine synthetase (*gcs-1*), glutathione-S-transferase (*gst-1, 4, 5, 38*), and uridine 5\'-diphospho-glucuronosyltransferase (*ugt-8, 25, 58*), compared to empty vector treated wild type (N2) (+), determined by qRT-PCR. 3 replicates of \>1000 mixed staged worms per condition were analysed. Data are represented as mean ± s.e.m. *P* value \* \<0.05, \*\* \<0.001, \*\*\* \<0.0001 relative to wild type or control, by one sample *t*-test, two-tailed, hypothetical mean of 1. (**F--I**) Loss of *memo-1* increases the expression of oxidative stress response genes *gst-4* and *gcs-1* in the intestine. (**F**) shows representative pictures of *dvIs19* \[P*gst-4*::GFP\] transgenic adult *C. elegans* treated with empty vector (upper picture; category: none) or *memo-1(RNAi\#1)* (lower picture; category: high). Anterior to the right, ventral side up. Scale bar = 100 µm. (**G--I**) Quantification of transgenic worms containing the promoter of *gst-4* or *gcs-1* fused with GFP (*dvIs19* \[P*gst-4*::GFP\] and *ldIs003* \[*Pgcs-1*::GFP\]. Scoring is described in Material and methods. Three trials are shown with N \> 60 for each condition and trial. *P* value by chi^2^ (\* \<0.05; \*\* \<0.001; \*\*\*p\<0.0001). (**J**) Survival of one-day old adult *memo-1(gk345)* mutants or wild type (N2) in sodium arsenite (5 mM) was assayed. *P* value determined by log-rank. Statistics and additional oxidative stress data either with arsenite or *tert*-butyl hydrogen peroxide are shown in [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.002](10.7554/eLife.19493.002)10.7554/eLife.19493.003Figure 1---figure supplement 1.MEMO-1 is a conserved protein that is expressed in many tissues in *C. elegans*.(**A**) Alignment of human Memo1 with *C. elegans* MEMO-1 amino acid sequence shows high conservation. Human Memo1 Isoform 1 (297 amino acids; Q9Y316 uniprot.org) was aligned with *C. elegans memo-1* isoform b (350 amino acids; wormbase.org). 153 out of 297 amino acids (52%) are identical between human and *C. elegans.* Stars indicate identical amino acids, single dots indicate that size or hydropathy is conserved, and double dots indicate that both size and hydropathy are conserved between the corresponding residues. The amino acids that bind copper are conserved in *C. elegans* (H49, H81, D189, H192, C244 \[[@bib55]\]) and are indicated with red chevrons. T-coffee was used for the alignment ([@bib66]). (**B--H**) *memo-1* is expressed in neuronal and non-neuronal cells throughout development and adulthood (**B**). Promoter *memo-1* driven green fluorescent protein (GFP) (*jxEx8* \[P*memo-1*::GFP\]) animals are shown. (**C**) P*memo-1*::GFP is expressed in some neurons in the head of an L4 wild-type worm, e.g., amphid neurons, including ASJ, and also non-neuronal tissues, such as the pharynx (the procorpus, the anterior bulb, the isthmus and the terminal bulb). (**D**) In young, adult wild-type worms, P*memo-1*::GFP is expressed in tail neurons, the posterior end of the intestine and the rectal area. Strong P*memo-1*::GFP expression in tail neurons (arrow) and weaker expression in the posterior end of the intestine (**i**) and the rectal area (**r**). (**E**) P*memo-1*::GFP is expressed in the adult vulva. (**F**) P*memo-1*::GFP is expressed in the spermatheca of wild-type adults. (**G**) P*memo-1*::GFP is expressed during vulva development at the L4 stage. In an early L4, P*memo-1*::GFP::GFP is expressed weakly around the vulva and expressed strongly in the anchor cell (arrow) and the vulval precursor cells (chevrons). There is also strong expression in the ventral cord neurons. Note that P*memo-1*::GFP is expressed in vulva precursor cells similar to EGFR expression ([@bib27]). (**H**) P*memo-1*::GFP is expressed in the distal tip cells (arrow). For images (**C--H**): Top panel shows the Nomarski image and bottom panel the corresponding P*memo-1*::GFP expression. Anterior of the worm is to the left and the ventral side is down; the focus is on the middle plane at 100x magnification. (**I**) Translational fusion of MEMO-1 with GFP (*ldEx112* \[MEMO-1fosmid::GFP\] is localized to head neurons and pharynx surrounding cells (head; upper picture) and intestinal cells (tail; bottom picture). Scale bar = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.003](10.7554/eLife.19493.003)10.7554/eLife.19493.004Figure 1---figure supplement 2.Reverse genetics approach to determine *memo-1* function.(**A--B**) EGFR phenotypes are not affected by *memo-1*. EGFR/*let-23* mutants fail to form a vulva ([@bib20]) and as a result, EGFR mutants incarcerate their progeny resulting in bags of worms (bagging; \[[@bib20]\]). The phenotype of the *let-23(n1045)* mutant has a weakly penetrant multiple vulva (Muv) phenotype at 25°C ([@bib20]). We crossed hermaphrodites of *let-23(n1045)* that were raised at 20°C either to wild type (N2) or *memo-1(gk345)* and placed them at 25°C. Three days later, we analyzed the heterozygous progeny for the Muv phenotype at 25°C. The control, which is the heterozygous *let-23(n1045)*/+; +/+ progeny, had a 27% Muv phenotype at 25°C, whereas the heterozygous *let-23(n1045)*/+; *memo-1(gk345)*/+ progeny had a 14% Muv phenotype at 25°C. A *t*-test showed no significant difference between the two populations for their Muv phenotype (not shown). (**A**) Developing vulva of *memo-1(gk345)* mutants looks superficially wild type (wildtype vulva not shown). Top panel shows Normarski image of a young L4 vulva and bottom panel of a late L4 vulva of *memo-1(gk345)* mutants. (**B**) *memo-1(gk345)* mutants do not show increased incidences of bagging. (**C**) The development speed of *memo-1(gk345)* mutants is similar to wild type (N \> 200; one representative trial out of 3 shown). (**D**) Top panel schematic: Chemotaxis on agar plates with the triangles indicating the start point for worms. 'X' indicates the pole where the compound used in the experiment is placed, and ethanol (EtOH) served as the negative control. 1 µl of sodium azide (NaN~3~) was added to both poles (green circles) to anesthetize the worms. Lower panel schematic: The agar plates were split into four quadrants. On the surface of the two opposite quadrants 100 mM sodium chloride was added. Tables display results. N \> 200 per condition. No statistical difference in chemotaxis was seen between *memo-1(gk345)* and wild type determined by *t-*test, unpaired, two-tailed. (**E**) Loss of *memo-1* does not affect insulin/IGF-1 signaling-mediated dauer formation. (**F**--**G**) Loss of *memo-1* does not affect gonadal migration or morphology at 20°C. (**F**) Anterior gonadal arm of wild type (upper panel) and *memo-1(gk345)* mutant (lower panel) at the L4 stage are shown. (**G**) Posterior gonadal arm of wild type (upper panel) and *memo-1(gk345)* mutant (lower panel) at the L4 stage are shown. For **F-G**: anterior of the worm is to the left and the ventral side is down; the focus is on the middle plane at 100x magnification. (**H--J**) Loss of *memo-1* does not affect neuroblast migration. Q neuroblasts and their descendants undergo long-range migration. At the L1 stage the Q neuroblasts divide into QL and QR, which generate some sensory neurons ([@bib93]). Both QR and QL descendants start to migrate from the midbody, with the QR descendants migrating anteriorly and the QL descendants migrating posteriorly, where they divide further to give rise to two of the sensory touch receptor neurons (AVM and PVM) ([@bib11]). To test if *memo-1* is involved in this migration, we used RNAi to knock down *memo-1* or *memo-1(gk345)* mutants in transgenic *muIs32* \[P*mec-7*::GFP\] animals that express GFP in the Q neuroblasts and their descendants (six touch neurons (ALML, ALMR, AVM, PLML, PLMR, and PVM; \[[@bib11]\]). (**H--I**) Representative transgenic P*mec-7*::GFP animal either in wild-type background (left panel) or *memo-1(gk345)* mutant background (right panel) before migration of Q neurobasts starts (**G**) at L1 and after migration (**H**) at L4. Loss of *memo-1* with *memo-1(gk345)* mutation revealed no deficiency in the migration of the AVM and PVM cells. (**J**) Representative images of transgenic P*mec-7*::GFP animal in an *eri-1(mg366); lin- 15b(n744)* mutant background treated either with empty vector RNAi (L4440; left panel) or *memo-1(RNAi\#1 or \#2)* (right panel; shown is *memo-1(RNAi\#2)*). The *eri-1; lin-15b* double mutations renders the worm neurons more sensitive to feeding-induced RNAi ([@bib42]). Knocking down *memo-1* with *memo-1(RNAi\#1 or \#2)* did not prevent the migration of the AVM and PVM cells. For all images: anterior of the worm is to the left and the ventral side is down; the focus is on the middle plane at 100x magnification. For (**H--I**) the same worm is shown per column: top picture is bright field, middle picture is merged GFP with bright field, and bottom picture is GFP channel.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.004](10.7554/eLife.19493.004)10.7554/eLife.19493.005Figure 1---figure supplement 3.Reduced *memo-1* function induces oxidative stress gene expression.(**A**) Caloric restriction has been shown to extend lifespan in many species ([@bib44]). Thus, we tested if the *memo-1(gk345)* mutants are calorically restricted. A genetic model for caloric restriction in the worm has an Eat phenotype, i.e., this worm has a pumping defect in its pharynx, preventing the animal from eating efficiently ([@bib48]). Since P*memo*::GFP is expressed in the pharyngeal area ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1C and l](#fig1s1){ref-type="fig"}), we analyzed *memo-1(gk345)* mutants for a pharyngeal pumping defect as a readout of feeding rate. *memo-1(gk345)* mutants did not have altered pharyngeal pumping compared to wild type (N2) at the L4 stage (N = 10 per strain, *P* value 0.8747 determined with *t*-test unpaired two-tailed). (**B**) Loss of *memo-1* does not affect progeny production. Brood size for wild type (N2) (268 ± 15) and for *memo-1(gk345)* mutants (292 ± 11) was not significantly different. Data represented as mean + s.e.m., *P* value = 0.1953 determined with *t-*test, unpaired, two-tailed. (**C**) Genes involved in the heat shock response, in the germ stem cell-less-mediated longevity (*glp-1*), and in the unfolded protein response (UPR) are not induced in *memo-1(gk345)* mutants, as determined by qRT-PCR for the indicated transcripts. N \> 200 L4 animals, two merged independent trials in duplicates. *xbp-1u* = unspliced, *xbp-1s* = spliced. (**D--F**) Loss of *memo-1* does not affect insulin/IGF-1 signaling. (**D**) Schematic of insulin/IGF-1 receptor signaling to DAF-16/FOXO in *C. elegans*. Under normal conditions, insulin/IGF-1 receptor (*daf-2*) signaling retains the FOXO transcription factor DAF-16 in the cytoplasm. When insulin/IGF-1 signaling is reduced, DAF-16 translocates into the nucleus to initiate transcription of target genes (*sod-3, btb-14, lipl-4, mlt-1, lea-1*). (**E**) Downstream targets of DAF-16/Foxo transcription factor that are upregulated when insulin/IGF-1 receptor (*daf-2*) signaling is reduced (rIIS) are not altered in *memo-1(gk345)* mutant animals. (**F**) DAF-16::GFP translocates into the nucleus with *daf-2* knockdown (not shown), but not with *memo-1* knockdown (N \> 60 per condition; *zIs356* \[DAF-16::GFP\]). (**G**) *memo-1(gk345)* mutants have higher mRNA levels of oxidative stress response genes *gcs-1* and *gst-4* compared to wild type (N2), as determined by qRT-PCR. For each condition, two biological samples in duplicates of 200 L4 worms each were analyzed by qRT-PCR. All data are represented as mean ± s.e.m. *P* values of \* \<0.05 relative to wild type (N2) control, determined by one sample *t*-test, two-tailed, hypothetical mean of 1. (**H**) *memo-1* mutants are not heat stress resistant. Day one wild type (N2) and *memo-1(gk345)* mutants were placed at 35°C and scored every hour for survival (N = 100 per strain). There is no significant difference between wild type (N2) and *memo-1(gk345)* for heat stress survival determined with log-rank (Mantel-Cox) method to calculate *P* value = 0.1594.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.005](10.7554/eLife.19493.005)

Dietary restriction extends lifespan across essentially all eukaryotes ([@bib44]). Since MEMO-1 is expressed around the pharynx ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}), an organ that regulates food intake, we measured pharyngeal pumping rates of *memo-1*(-) mutants, finding them to be similar to those of wild type ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). Reducing germline stem cell number also increases *C. elegans'* lifespan ([@bib36]) and MEMO-1 is expressed in cells associated with the germline ([Figure 1---figure supplement 1F and H](#fig1s1){ref-type="fig"}). However, *memo-1(-)* mutants did not show germ-line defects ([Figure 1---figure supplement 2F and G](#fig1s2){ref-type="fig"}). Not only did they have a normal brood size ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}), they also showed no upregulation of genes implicated in reduced germline stem cell-mediated longevity ([Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}).

To identify cellular processes that promote the *memo-1(-)*-longevity phenotype, we performed quantitative RT-PCR on selected target genes involved in known longevity-promoting processes, comparing *memo-1(-)* mutants with wild type ([Figure 1---figure supplement 3C--G](#fig1s3){ref-type="fig"}). We concentrated on stress response pathways, since longevity frequently correlates with increased stress resistance ([@bib89]). Several genes involved in the oxidative stress response were strongly upregulated (3--10 fold) in the *memo-1* mutants or by *memo-1(RNAi),* compared to wild type or empty vector control strains ([Figure 1E--I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3G](#fig1s3){ref-type="fig"}). By contrast, genes involved in the heat shock response, the unfolded protein response (UPR) and other longevity-promoting processes were not altered in *memo-1(-)* animals ([Figure 1---figure supplement 3C and E](#fig1s3){ref-type="fig"}). Importantly, downregulation or loss of *memo-1* by RNAi or mutation increased oxidative stress resistance, correlating with the observed changes in gene expression ([Figure 1J](#fig1){ref-type="fig"}, [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}). By contrast, its loss did not increase resistance to heat shock ([Figure 1---figure supplement 3H](#fig1s3){ref-type="fig"}). Taken together, these results suggest that a elevated oxidative stress resistance might be an important factor in *memo-1(-)*-longevity.

Loss of *memo-1* activates p38 MAPK signaling and the oxidative stress response transcription factor SKN-1 {#s2-2}
----------------------------------------------------------------------------------------------------------

The major oxidative stress response is orchestrated by the transcription factor SKN-1, a homologue of the NRF1/2/3 (Nuclear factor-erythroid-related factor) bZIP transcription factor family ([@bib3]). Several of the oxidative stress response genes that are upregulated by *memo-1* knockdown or mutation are direct transcriptional targets of SKN-1 ([Figure 2---source data 1](#SD1-data){ref-type="supplementary-material"}). Thus, we examined the role of *skn-1* in the *memo-1* phenotype. Knockdown of *skn-1* by RNAi abolished the longevity phenotype of *memo-1(-)* mutants ([Figure 2A](#fig2){ref-type="fig"}; [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Conversely, *memo-1(RNAi)* knockdown increased lifespan of wild-type animals but not of *skn-1(-)* mutants ([Figure 2B](#fig2){ref-type="fig"}; [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). These results suggest that the extended lifespan of animals that lack *memo-1* is mediated through SKN-1.10.7554/eLife.19493.006Figure 2.The oxidative stress response pathway is activated and is required for *memo-1(-)* mediated longevity and oxidative stress resistance.(**A**) Knockdown of *skn-1* starting on the first day of adulthood abolishes the increased lifespan of *memo-1(gk345)* mutants. For statistical details and additional lifespans see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**B**) Knockdown of *memo-1(RNAi\#1)* starting on the first day of adulthood increases lifespan of wild type (N2) animals, but failed to increase lifespan of *skn-1(zu67)* loss-of-function mutants. For statistical details and additional strains see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**C**) Schematics and representative pictures of transgenic L4 animals expressing a translational fusion of SKN-1 protein tagged with GFP (*ldIs007* \[SKN-1::GFP\]), treated either with empty vector (upper picture; no SKN-1::GFP in intestine = score none) or *memo-1(RNAi\#1)* (bottom picture; SKN-1::GFP in all intestinal nuclei = score high). Scale bar = 20 µm. Triangles indicate intestinal nuclei. (**D**) Quantification of SKN-1::GFP in L4 transgenic animals: Knockdown of *memo-1(RNAi \#1 or \#2)* starting from the egg stage induced translocation of SKN-1::GFP into the intestinal nuclei. N \> 60, three merged trials. \*\*\* \<0.0001 *P* values were determined by Chi^2^ test. Scoring is described in Material and Methods. (**E**) p38 mitogen-activated protein kinase is phosphorylated (P-p38 MAPK) upon oxidative stress (WT arsenite; 5 mM sodium arsenite for 10 min) or in untreated *memo-1(gk345)* mutants, compared to untreated wild type (WT untreated). (**F**) Knockdown of *memo-1(RNAi \#1 or \#2)* for two generations led to an increase p38 phosphorylation levels compared to empty RNAi vector control wild type animals. For (**E--F**) Total extracts from \>1000 L4 animals in each condition were analyzed by western for levels of P-p38. Actin was used as a loading control. Fold change indicates the relative P-p38 MAPK to actin levels compared to control (E: WT untreated; F: WT empty RNAi vector control). (**G**) Knockdown of *memo-1(RNAi\#1)* starting on the first day of adulthood increases lifespan of wild type (N2) animals, but failed to increase lifespan of *sek(km4)* loss-of-function mutants. For statistical details and additional trials see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**H**) Schematic of the oxidative stress response pathway in *C. elegans*. Oxidative stress activates SEK-1/MAPKK phosphorylating p38 MAPK phosphorylating the SKN-1/Nrf transcription factor, promoting its nuclear translocation, which initiates transcription of oxidative stress response genes (e.g., *gcs-1* and *gst-4*).**DOI:** [http://dx.doi.org/10.7554/eLife.19493.006](10.7554/eLife.19493.006)10.7554/eLife.19493.007Figure 2---source data 1.Oxidative stress response genes upregulated by loss of *memo-1* are transcriptional targets of SKN-1.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.007](10.7554/eLife.19493.007)

To determine whether loss of *memo-1* activates SKN-1, we examined the cellular localization of GFP-tagged SKN-1. Under normal conditions SKN-1 is largely retained in the cytoplasm; following oxidative stress, SKN-1 accumulates in the nucleus to initiate transcription of target genes ([@bib3]). RNAi-mediated *memo-1* knockdown caused a significant increase in nuclear SKN-1::GFP ([Figure 2C and D](#fig2){ref-type="fig"}). Under oxidative stress conditions, SKN-1 phosphorylation/activation is mediated by p38 mitogen-activated protein kinase (MAPK; \[[@bib39]\]), which is phosphorylated and activated by SEK-1/MAPKK ([@bib39]; [@bib35]). Importantly, reducing *memo-1* function either by RNAi or mutation resulted in higher levels of phospho-p38 MAPK ([Figure 2E and F](#fig2){ref-type="fig"}), and loss of *sek-1* completely abolished *memo-1(-)* mediated-longevity ([Figure 2G](#fig2){ref-type="fig"}). Since *sek-1* and *skn-1* are important for the defense against pathogenic bacteria ([@bib33]), and bacterial proliferation in the *C. elegans'* intestine contributes to death of the animal ([@bib22]), we investigated the lifespan of *memo-1* mutants on heat-killed bacteria. We found that *memo-1* mutants remain long-lived compared to wild type ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Taken together, these results show that *memo-1* loss stimulates the p38 MAPK oxidative stress response pathway ([Figure 2H](#fig2){ref-type="fig"}), which is required for the longevity phenotype.

Loss of *memo-1* leads to increased ROS {#s2-3}
---------------------------------------

The increase in the oxidative stress response pathway observed in the preceding experiments suggested that ROS levels might be altered in *memo-1* animals. To examine this, we measured intracellular ROS in living worms using a diffusible fluorescent probe (chloromethyl derivative CM-H~2~DCFDA) and observed a 2-fold increase upon treatment of wild-type *C. elegans* with *memo-1(RNAi)* ([Figure 3A](#fig3){ref-type="fig"}). Moreover, compared to control worms, transgenic worms that express the HyPer sensor (*jrIs1* \[[@bib5]\]) and have been treated with *memo-1(RNAi)* have a 5-fold increase in endogenous hydrogen peroxide levels ([Figure 3B](#fig3){ref-type="fig"}), while *memo-1* mutant or RNAi-treated animals have a 2-fold increase in hydrogen peroxide, according to the fluorescent probe AmplexRed ([Figure 3C and D](#fig3){ref-type="fig"}). Interestingly, ROS levels in the *memo-1(RNAi)* and the *memo-1(RNAi); sek-1(RNAi)* animals were elevated to a similar level ([Figure 3E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}), suggesting that the SKN-1 adaptive response did not necessarily reduce the overall ROS load. Additionally, *memo-1(-)*-impaired animals that lack ROS protection in a *skn-1(-)* ([Figure 2B](#fig2){ref-type="fig"}) or *sek-1(-)* mutant background ([Figure 2G](#fig2){ref-type="fig"}) did not live shorter than either *skn-1(-)* or *sek-1(-)* single mutants in the absence ([Figure 2B and G](#fig2){ref-type="fig"}) or presence of the oxidative stress-inducing agent 5 mM arsenite ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"} and [2](#SD3-data){ref-type="supplementary-material"}). Taken together, these results suggest that the increased ROS levels in animals that lack *memo-1* are not necessarily detrimental.10.7554/eLife.19493.008Figure 3.Increased ROS resulting from loss of *memo-1* function is required for longevity.(**A**) Knockdown of *memo-1* increases endogenous ROS levels *in vivo*, measured using the CM-H~2~DCFDA fluorescent molecular probe. (**B**) Knockdown of *memo-1* increases endogenous hydrogen peroxide levels, measured in transgenic HyPer worms (*jrIs1*\[P*rpl-17*::HyPer\]), to a similar extent as measured in EV fed animals treated with 5 mM sodium arsenite for 10 min (EV and arsenite). (**C--D**) Knockdown of *memo-1* (**C**) and *memo-1(gk345)* mutants (**D**) have higher hydrogen peroxide levels *in vivo* compared to wild type (N2) control, as measured with AmplexRed. (**E**) Knockdown of *sek-1* does not suppress the higher hydrogen peroxide levels induced by *memo-1(RNAi)* measured with AmplexRed. (**F**) Loss of *sek-1* completely suppresses the *memo-1(-)* mediated oxidative stress resistance. For statistical details and additional trials see [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}. (**G**) Treatment with the antioxidant glutathione (GSH) completely suppresses the higher endogenous hydrogen peroxide levels of transgenic HyPer worms (*jrIs1*\[P*rpl-17*::HyPer\]) treated with *memo-1(RNAi)* or by measurement with Amplex Red ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Eggs were hatched on empty vector (EV) or *memo-1(RNAi)* food with 5 mM GSH or with solvent (H~2~O; control) and harvested for assay at larval stage 4 (L4). (**H**) The antioxidant glutathione (GSH) completely suppresses the longevity of *memo-1(gk345)* mutants. For statistical details and additional trials with *memo-1(RNAi)* see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**I**) The antioxidant glutathione (GSH) completely suppresses the induction of oxidative stress response gene *gst-4* in response to *memo-1* knockdown. Transgenic animals *dvIs19* \[P*gst-4*::GFP\] were placed on empty vector (EV) or *memo-1(RNAi)* food with 5 mM GSH or solvent (H~2~O; control) for two generations and day one adults were scored. N \> 60, three merged trials. \*\*\* \<0.0001 *P* values were determined by Chi^2^ test. Scoring is described in Material and methods. For (**A--C, E**) Eggs were hatched on empty vector (EV) or *memo-1(RNAi)* food and harvested for the assay at larval stage 4 (L4). For (**A--E, G**) N \> 1000 for each condition, three merged trials. All data are represented as mean ± s.e.m. *P* values \* \<0.05 relative to wild-type on EV or (**D**) to wild type (N2), determined by one sample *t*-test, two-tailed, hypothetical mean of 1.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.008](10.7554/eLife.19493.008)10.7554/eLife.19493.009Figure 3---figure supplement 1.Reduced *memo-1* function induces NADPH oxidase specific ROS.(**A**) Knockdown of *memo-1* does not increase *in vivo* mitochondrial localized ROS levels as measured with MitoTracker Red CM-H~2~XRos fluorescent molecular probe. As a control, and run in parallel, *memo-1(RNAi)* was sufficient to increase hydrogen peroxide measured by Amplex Red, and this was not suppressed by *sek-1(RNAi)* or by treatment with the mitochondrial specific antioxidant MitoTempo. Eggs were hatched on empty vector (EV) or *memo-1(RNAi)* (or double RNAi with a ratio 1:1) food and harvested for the assay at larval stage 4 (L4). N \> 1000 per condition in this single trial. (**B**) Knockdown of *sek-1* does not suppresse the higher endogenous hydrogen peroxide levels of transgenic HyPer worms (*jrIs1*\[P*rpl-17*::HyPer\]) treated with *memo-1(RNAi).* (**C**) The antioxidant glutathione (GSH) completely suppresses the elevated hydrogen peroxide levels of wild-type animals treated with *memo-1(RNAi)*, as measured by Amplex Red. Eggs were hatched on empty vector (EV) or *memo-1(RNAi)* food in the presence of 5 mM GSH or solvent (control) and harvested for the assay at L4. (**D**) Knockdown of *bli-3*/ NADPH oxidase completely suppresses the higher endogenous hydrogen peroxide levels of transgenic HyPer worms (*jrIs1*\[P*rpl-17*::HyPer\]) treated with *memo-1(RNAi).* A 1:10 ratio for the double RNAi treatment with *bli-3* was used. For (**J--L**) N \> 1000 for each condition, three merged trials each with three replicates. All data are represented as mean ± s.e.m. *P* values \* \<0.05 and \*\*\* \<0.0001 relative to wild-type on EV were determined by one sample *t*-test, two-tailed, hypothetical mean of 1.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.009](10.7554/eLife.19493.009)

An intriguing possibility suggested by the data is that *memo-1(-)*-induced ROS might have longevity-promoting activities analogously to mitochondrially-derived ROS. To investigate this hypothesis, we neutralized *memo-1(RNAi)*-produced ROS by treatment with the antioxidant glutathione (GSH) ([Figure 3G](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). GSH treatment during adulthood had no effect on wild-type lifespan, but abolished *memo-1(*-)-induced longevity ([Figure 3H](#fig3){ref-type="fig"}, [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}), suggesting an essential role for *memo-1(-)*-induced ROS in this process. Furthermore, GSH treatment abolished the induction of the SKN-1 target gene *gst-4* ([Figure 3I](#fig3){ref-type="fig"}), indicating that the *memo-1(RNAi)-*induced ROS are responsible for SKN-1 activation.

Excess ROS in *memo-1(-)* animals is generated by the dual oxidase BLI-3 {#s2-4}
------------------------------------------------------------------------

SKN-1 has been implicated in ROS-induced hormesis and ROS signaling ([@bib8]). Indeed, mitochondrially-generated ROS have been observed to increase lifespan via SKN-1 ([@bib80]; [@bib97]; [@bib81]; [@bib37]). To determine if excess ROS in *memo-1(-)* mutants are generated from mitochondria, we used a specific mitochondrial ROS-detecting reagent, MitoTracker Red CM-H~2~X ([@bib97]), revealing that the *memo-1(RNAi)* animals had similar mitochondrial ROS levels as the controls ([Figure 4A](#fig4){ref-type="fig"}). Furthermore, a mitochondria specific-antioxidant, MitoTEMPO, neither suppressed the higher ROS levels nor elevated the *gst-4* expression levels ([Figure 4C](#fig4){ref-type="fig"}) seen in *memo-1(RNAi)*-treated animals ([Figure 4B](#fig4){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). The level of *hsp-6* expression, a measure of the mitochondrial unfolded protein response and of high mitochondrial ROS levels ([@bib76]), remained at control levels in *memo-1(RNAi)* animals ([Figure 4D](#fig4){ref-type="fig"}). Moreover, the longevity of *memo-1(RNAi)* treated animals was additive to the longevity of electron transport chain mitochondrial mutant *isp-1(qm150)* ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Lastly and importantly, a low dose of mitochondrial ROS require *sod-3* (superoxide dismutase) for extending lifespan ([@bib101]) and *memo-1(-)* longevity is independent of *sod-3* ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Taken together, these data show that the *memo-1(-)* induced ROS are not generated by the mitochondria.10.7554/eLife.19493.010Figure 4.Loss of *memo-1* increases ROS via NADPH oxidase to extend lifespan.(**A**) Knockdown of *memo-1* does not increase mitochondrial localized ROS levels *in vivo*, measured with MitoTracker Red CM-H~2~XRos fluorescent molecular probe. In a parallel experiment, the same *memo-1(RNAi)* treatment was sufficient to increase hydrogen peroxide, as measured by Amplex Red ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). (**B**) The mitochondrial specific antioxidant MitoTempo did not suppress *memo-1(RNAi)* induced ROS, measured with Amplex Red. (**C**) The mitochondrial specific antioxidant MitoTempo did not suppress *memo-1(RNAi))* induced expression of *gst-4* (*dvIs19* \[P*gst-4*::GFP\]). N \> 60, three merged trials. \*\*\* \<0.0001 *P* values were determined by Chi^2^ test. Scoring is described in Material and methods. (**D**) The mitochondrial stress response gene *hsp-6* (*zcIs13* \[P*hsp-6*::GFP\]) was not induced by *memo-1(RNAi).* N \> 100 for each condition, three merged trials. As a control and run in parallel, *memo-1(RNAi)* was sufficient to increase P*gst-4*::GFP expression ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). (**E**) A short (15 min) treatment with the NADPH oxidase inhibitor Diphenyleneiodonium (DPI) completely suppressed the elevated hydrogen peroxide levels of wild-type worms treated with *memo-1(RNAi).* (**F**) Knockdown of *bli-3*/ NADPH oxidase completely suppressed the elevated hydrogen peroxide levels of wild-type worms treated with *memo-1(RNAi).* As reported in [@bib13], a 1:10 ratio for the double RNAi treatment with *bli-3* was used because of the strong *bli-3* blistering phenotype. For corresponding experiments with transgenic HyPer worms (*jrIs1*\[P*rpl-17*::HyPer\]), see [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}. (**G**) Adulthood specific knockdown of *bli-3*/ NADPH oxidase (undiluted RNAi) completely suppressed the longevity of *memo-1(gk345)* mutants. For statistical details and additional trials see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**H**) Knockdown of *bli-3*/ NADPH oxidase completely suppressed *memo-1(RNAi)* induced nuclear translocation of SKN-1 protein (*ldIs007* \[SKN-1::GFP\]). N \> 60, three merged trials. \*\*\* \<0.0001 *P* values were determined by Chi^2^ test. Scoring is described in Material and methods. (**I**) Transgenic worms overexpressing BLI-3 (*ldEx117*) alone, or triple transgenic worms (*ldEx118*) overexpressing BLI-3 and co-factors for NADPH oxidase complex maturation and stability (DOXA-1 and TSP-15; \[[@bib62]\]) showed an increased hydrogen peroxide level compared to control transgenic animals. Mixed stage worms, N \> 1000 for each condition, three merged trials. All data are represented as mean ± s.e.m. *P* values \* \<0.05 or \*\*\* \<0.0001 relative to transgenic control (*ldEx102*) were determined by one sample *t*-test, two-tailed, hypothetical mean of 1. (**J--M**) Triple transgenic worms (*ldEx118*) overexpressing BLI-3, DOXA-1, TSP-15 showed an increased lifespan compared to transgenic control (*ldEx102*). The increased lifespan was dependent on *bli-3* (**K**), *skn-1* (**L**), and ROS (**M**). (**J--M**) are from the same trial ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). *P*-value determined by log-rank. Overexpression of BLI-3 alone (*ldEx117*) was also sufficient to increase lifespan ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). For statistical details and additional trials see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. For (**A, B, E, F**) eggs were hatched on empty vector (EV) or *memo-1(RNAi)* (or double RNAi with a ratio 1:1, except where indicated) food, and harvested for assay at larval stage 4 (L4). N \> 1000 for each condition, three merged trials. All data are represented as mean ± s.e.m. *P* values \* \<0.05 or \*\*\* \<0.0001 relative to wild-type on EV were determined by one sample *t*-test, two-tailed, hypothetical mean of 1.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.010](10.7554/eLife.19493.010)10.7554/eLife.19493.011Figure 4---figure supplement 1.Loss of *memo-1* does not increase mitochondrial ROS.(**A**) Loss of *memo-1* does not increase *in vivo* mitochondrial localized ROS levels as measured with MitoTracker Red CM-H~2~XRos fluorescent molecular probe (five independent trials). To induce mitochondrial ROS, Antimycin A treatment on wild type was used as a control. (**B**) For two out of the five biological independent trials shown in (**A**), animal populations were split in half and the corresponding half was used to measure hydrogen peroxide in the supernatant with Amplex Red, in parallel to the mitochondrial ROS measurements with MitoTracker Red CMXRos. Mutants that lack *memo-1* showed an almost 2-fold increase in ROS measured with Amplex Red, but showed no significant difference in mitochondrial ROS compared to wild type measured with MitoTracker Red CM-H~2~XRos fluorescent molecular probe (**A**). For (**A--B**) N \> 1000 per condition per trial. All data are represented as mean ± s.e.m. *P* values \*\*\* \<0.0001 relative to wild type were determined by one sample *t*-test, two-tailed, hypothetical mean of 1. Note that (**B**) are only two independent trails and therefore fail any statistical significance.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.011](10.7554/eLife.19493.011)

The nicotinamide adenine dinucleotide phosphate oxidases (NADPH oxidase) are important sources of intracellular ROS ([@bib47]). To check if they have a role in ROS production in *memo-1(RNAi)*-animals, we treated these animals with diphenyleneiodonium (DPI), a general inhibitor of NADPH oxidase activity ([@bib92]). DPI treatment completely eliminated *memo-1(RNAi)-*induced ROS ([Figure 4E](#fig4){ref-type="fig"}). The *C. elegans* genome encodes two NADPH oxidase (NOX)-related genes, Duox1/BLI-3 and Duox2. NOX proteins contain an NADPH oxidase domain, while DUOX proteins possess an additional peroxidase domain. Duox2 is not expressed in adult *C. elegans*, while BLI-3 is mainly expressed and functional in the intestine and hypodermis ([@bib17]; [@bib13]). Importantly, knocking down *bli-3* completely eliminated *memo-1(-)*-induced ROS ([Figure 4F](#fig4){ref-type="fig"} and [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}), suggesting that this dual oxidase is required for ROS generation in the *memo-1(-)* animals.

BLI-3/NADPH oxidase is required and sufficient to extend lifespan via SKN-1 {#s2-5}
---------------------------------------------------------------------------

Next we examined the role of BLI-3 in the *memo-1(-)*-induced phenotype. Adult-specific knockdown of *bli-3* did not alter wild-type lifespan or longevity resulting from dietary restriction, reduced insulin/IGF-1 signaling or reduced mitochondrial electron transport chain activity ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}), but it completely eliminated the *memo-1(-)* longevity phenotype ([Figure 4G](#fig4){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Consistent with this, *bli-3* knockdown suppressed SKN-1 nuclear localization in *memo-1(RNAi)* animals ([Figure 4H](#fig4){ref-type="fig"}), suggesting that BLI-3-generated ROS signal to SKN-1. Conversely, overexpression of BLI-3 alone, or with its maturation/association partners DOXA-1 and TSP-15 ([@bib62]), was sufficient to generate higher ROS levels ([Figure 4I](#fig4){ref-type="fig"}) and to increase lifespan ([Figure 4J](#fig4){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}), which was reduced by *bli-3 (RNAi)* ([Figure 4K](#fig4){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). BLI-3-dependent longevity ([Figure 4J](#fig4){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}) required SKN-1 ([Figure 4L](#fig4){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}), and was suppressed by the antioxidant GSH ([Figure 4M](#fig4){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Taken together, these results suggest that MEMO-1 functions as an inhibitor of BLI-3; and elevated ROS in the absence of MEMO-1 confers an enhanced longevity phenotype. This is a novel function for the NADPH oxidase BLI-3, which is known to produce ROS for innate immune functions ([@bib13]).

MEMO-1 prevents RHO-1/GTPase from activating BLI-3/NADPH oxidase {#s2-6}
----------------------------------------------------------------

Loss of *memo-1* increases expression of the SKN-1-target gene *gst-4* in a *bli-3*-dependent manner ([Figure 5A](#fig5){ref-type="fig"}). By contrast, reduction of insulin/IGF-1 receptor signaling by *daf-2(RNAi)*, which induces *gst-4* via SKN-1 ([@bib19]; [@bib95]), was not blocked by *bli-3(RNAi)* ([Figure 5A](#fig5){ref-type="fig"} bars 5--7). These findings would suggest that MEMO-1 and DAF-2 act in parallel to each other.10.7554/eLife.19493.012Figure 5.MEMO-1 inhibits NADPH oxidase via RHO-1/GTPase.(**A**) Summary of the targeted RNAi screen using the SKN-1 target gene *gst-4* expression (*dvIs19* \[P*gst-4*::GFP\]) as a read-out for *memo-1(-)* induced NADPH oxidase activity. N \> 60, three merged trials. \*\*\* \<0.0001 *P* values were determined by Chi^2^ test. For individual trials see [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. Scoring is described in Material and methods. (**B**) Loss of *rho-1* completely suppresses the *memo-1(-)* mediated oxidative stress resistance. For statistical details see [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}. (**C**) Knockdown of *rho-1* lowered the *memo-1(-)* mediated ROS induction in all three independent biological trials. Eggs were hatched on empty vector (EV) or *rho-1(RNAi)*. All data are represented as mean ± s.e.m. *P* values \* \<0.05 and \*\*\* \<0.0001 relative to wild type EV control were determined by one sample *t*-test, two-tailed, hypothetical mean of 1. The *memo-1(gk345)* mutants treated with *rho-1(RNAi)* was compared to the *memo-1(gk345)* mutants treated with EV using paired *t*-test, one-tailed. (**D**) The longevity of *memo-1(gk345)* mutants was completely suppressed by adulthood specific knockdown of *rho-1*. For statistical details see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**E**) The longevity of triple transgenic worms (*ldEx118*) overexpressing BLI-3, DOXA-1, TSP-15 was partially suppressed by adulthood specific knockdown of *rho-1*. For statistical details see [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. (**F**) MEMO-1 physically interacts with RHO-1 under wild-type conditions. Lysates from MEMO-1::GFP expressing animals *ldEx112* \[MEMOfosmid::GFP\] were subjected to immunoprecipitations with a *C. elegans* specific RHO-1 antiserum and immunoblotted with a GFP antibody following SDS-PAGE. (**G**) Knockdown of *memo-1* enhances the physical interaction of RHO-1 with BLI-3. Endogenous RHO-1 was immunoprecipited from lysates of wild type worms fed either EV or *memo-1(RNAi)* using RHO-1 antibody and was immunoblotted with BLI-3 antiserum. The relative BLI-3 levels in Co-IP samples to input samples is expressed as a fold change of *memo-1(RNAi)* to the empty vector control (EV). (**H**) Feedback loop: The *memo-1* promoter contains four predicted SKN-1 binding sites (wormbase.org). In a genome-wide screen, transgenic SKN-1::GFP showed a high signal on two *skn-1*-binding sites in the *memo-1* promoter region (upper panel; \[[@bib64]\]). Lower panel shows that the *memo-1* mRNA levels are lower in *skn-1(zu67)* loss-of-function mutants and higher in conditions of SKN-1 overexpression (*ldIs007* \[SKN-1::GFP\]) and constitutively nuclear SKN-1 overexpression (*ldIs020* \[SKN-1S393::GFP\]; \[[@bib95]\]) in transgenic animals, compared to wild type (N2), determined by qRT-PCR. Three biological samples of each 100 L4 worms per strain per trial. Data are represented as mean ± s.e.m. *P* value \* \<0.05, \*\* \<0.001, \*\*\* \<0.0001 relative to wild type or control, by one sample *t*-test, two-tailed, hypothetical mean of 1.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.012](10.7554/eLife.19493.012)10.7554/eLife.19493.013Figure 5---figure supplement 1.Targeted RNAi screen to discover genes mediating *memo-1* activation of SKN-1.(**A**) Schematic outline of the targeted RNAi screen. Eggs were placed on RNAi food and early adults (left panel) were scored for their *gst-4* (*dvIs19* \[P*gst-4*::GFP\]) induction in the intestine (right panel). Scoring is described in Material and methods. We screened more than 200 genes; the positive hits were retested and results are represented in the graphs. For (**B--F**): each graph shows 1 trial with 2--3 replicates with N \> 60 for each condition and replicate. RNAi clones were sequenced to confirm their identity. Mammalian homologues or the gene family are indicated. (**B**) *skn-1(RNAi)* completely abolishes *gst-4* expression. (**C**) The dual oxidase (Duox) BLI-3 and RHO-1 (Rho GTPase), but not CDC-42 (Rho GTPase; see F) are required for *memo-1(RNAi)* induced *gst-4* expression. (**D**) The *p21*-activated kinase PAK-1 is required for *memo-1(RNAi)* induced *gst-4* expression. (**E**) The Duoxa1 (Duox maturation factor) *doxa-1*, *rac-2* (RAC/GTPase), but not *ced-10* (RAC/GTPase) are required for *memo-1(RNAi)* induced *gst-4* expression. Reducing *daf-2*/insulin/IGF-1 receptor (InsR/IGF-1R) signaling induces *gst-4* expression and this is additive to *memo-1(RNAi)* induced *gst-4* expression. (**F**) *pes-7*/IQGAP is completely and *unc-60*/cofilin is partially required for *memo-1(RNAi)* induced *gst-4* expression. Importantly, *bli-3(RNAi)* does not block *gst-4* expression *per se*, since *daf-2(RNAi)*-mediated *gst-4* expression was still occurring even when *bli-3* was knocked down. Several potential interesting candidates were not required for *memo-1(RNAi)* induced *gst-4* expression, including *shc-1, shc-2, plc-3, let-60, cup-4, pkc-3*.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.013](10.7554/eLife.19493.013)

To determine how MEMO-1 inhibits BLI-3 activity, we took a genetic approach. Loss of genes that are required for the downstream signaling in *memo-1(-)* animals should also eliminate *gst-4* upregulation in a manner similar to *bli-3* knockdown ([Figure 5A](#fig5){ref-type="fig"}). Therefore, we performed a targeted RNAi screen on selected genes. We screened genes that are known to activate NADPH oxidase, as well as genes that either interact with, or might potentially interact with MEMO-1 ([Figure 5---figure supplement 1A--F](#fig5s1){ref-type="fig"}). In this screen, we identified known activators of mammalian NADPH oxidases, such as *rac-2*, a Rho family GTPase, *pak-1,* the p21-activated kinase ([@bib91]; [@bib38]), *doxa-1,* the *C. elegans* BLI-3 maturation factor ([@bib62]), *pes-7*/IQGAP, the actin-binding Rho GTPase activator and NRF2 binding partner ([@bib45]), and two interactors of mammalian Memo1: the actin-binding depolymerizing factor *unc-60*/cofilin ([@bib58]) and the homologue of the mammalian RhoA GTPase *rho-1* ([@bib91]).

In mammalian models, it has been shown that RhoA interacts with Memo1 in pull-down assays ([@bib103]). Moreover, ectopic expression of a gain-of-function mutant RhoA (V14) rescued breast cancer cells from migration-related defects ([@bib103]). Thus, in the following experiments we concentrated on the MEMO-1/RHOA interaction in worms.

To test whether *C. elegans rho-1* is required for *memo-1(-)*-induced oxidative stress resistance, we knocked-down *rho-1* in *memo-1(RNAi)* animals, which resulted in complete elimination of their oxidative stress resistance ([Figure 5B](#fig5){ref-type="fig"} and [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}). Knocking down *rho-1* in *memo-1(gk345)* mutants partially suppressed the *memo-1(-)* ROS induction ([Figure 5C](#fig5){ref-type="fig"}). Moreover, adult-specific knockdown of *rho-1* completely suppressed the longevity of *memo-1(gk345),* and partially blocked the lifespan extension from BLI-3 overexpression ([Figure 5D and E](#fig5){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Next, we examined whether MEMO-1 and RHO-1 physically interact in *C. elegans* lysates, by performing co-immunoprecipitation (Co-IP) of endogenous RHO-1 followed by immunoblot analysis of GFP-tagged MEMO-1. Under normal conditions, MEMO-1 and RHO-1 are found in a complex ([Figure 5F](#fig5){ref-type="fig"}). Since loss of *memo-1* in *C. elegans* leads to higher ROS levels that are dependent on the NADPH oxidase BLI-3, we tested whether RHO-1 and BLI-3 also interact using lysates from control and *memo-1-*impaired animals. Co-immunoprecipitation with a RHO-1 antibody revealed that under normal conditions endogenous RHO-1 physically binds to endogenous BLI-3 *in vivo*. However, we found 2.25-fold higher levels of the BLI-3 bound to RHO-1 in lysates from *memo-1* knockdown worms ([Figure 5G](#fig5){ref-type="fig"}). These findings suggest that MEMO-1 regulates the RHO-1/BLI-3 interactions necessary for BLI-3 function, a model that is consistent with our genetic findings.

Interestingly, the *memo-1* promoter contains four predicted SKN-1 binding sites (wormbase.org). In a genome-wide screen, transgenic SKN-1::GFP showed a high signal on two of the four sites in the *memo-1* promoter region ([Figure 5H](#fig5){ref-type="fig"}, upper panel; \[[@bib64]\]), suggesting that SKN-1 regulates *memo-1* transcription. Consistent with this, *memo-1* mRNA levels are lower in *skn-1(zu67)* loss-of-function mutants and, conversely, higher in transgenic animals with either SKN-1 overexpression (*ldIs007* \[SKN-1::GFP\]), or constitutive nuclear SKN-1 overexpression (*ldIs020* \[SKN-1S393::GFP\]; \[[@bib95]\]), when compared to wild type.

These results suggest a model whereby MEMO-1 controls the level of RHO-1 that is bound to BLI-3, and thereby regulates BLI-3 activity ([Figure 6](#fig6){ref-type="fig"}). In animals with *memo-1* knockdown RHO-1 is free to bind and activate BLI-3/NADPH oxidase, thereby generating an increase in intracellular ROS. These ROS presumably act as a longevity-promoting signal molecule that activates both p38 MAPK and the SKN-1/Nrf1,2,3 transcription factor, which would increase the level of transcripts involved in the oxidative stress response, thus lengthening lifespan. Furthermore, activation of SKN-1 increases the expression of *memo-1* ([Figure 5H](#fig5){ref-type="fig"}), suggesting a negative feedback loop that regulates ROS generation by the BLI-3/NADPH oxidase ([Figure 6](#fig6){ref-type="fig"}) in order to maintain a homeostatic balance.10.7554/eLife.19493.014Figure 6.Model of how MEMO-1 activates NADPH oxidase activity to promote oxidative stress resistance and longevity.Under normal conditions, MEMO-1 is complexed with RHO-1/GTPase. Loss of *memo-1* frees RHO-1 to enhance BLI-3/NADPH oxidase activity to generate localized ROS, which activates p38 MAPK signaling to SKN-1 to transcribe genes important for oxidative stress resistance and longevity. Similar to ERBB2 recruiting Memo1 in breast cancer cells ([@bib56]), we speculate that in *C. elegans* a stimulus might activate a cell-surface receptor to recruit MEMO-1, thereby freeing RHO-1 to promote BLI-3/NADPH oxidase activity. Because SKN-1 also transcribes *memo-1* ([Figure 5H](#fig5){ref-type="fig"}) resulting in a negative feedback loop to shut off BLI-3/NADPH oxidase activity, *memo-1* RNAi or mutation breaks this feedback loop, resulting in continuously enhanced BLI-3 activity.**DOI:** [http://dx.doi.org/10.7554/eLife.19493.014](10.7554/eLife.19493.014)

Discussion {#s3}
==========

NADPH oxidases are a major source of cellular ROS ([@bib47]), but the possibility that the ROS they produce might influence longevity-associated mechanisms has not been explored. In *C. elegans*, we have identified a pathway that regulates ROS production via an increase in BLI-3/NADPH oxidase activity. We show that MEMO-1 is a negative regulator of BLI-3, and that its loss enhances an interaction between RHO-1 and BLI-3, thereby stimulating the activity of this NADPH oxidase. As a result, ROS are generated that activate p38 and induce nuclear accumulation of SKN-1/Nrf, and thereby promote stress resistance and longevity in this metazoan. Thus, our data identify a regulatory mechanism that controls ROS generation, which is sufficient to promote longevity; they also show that this mechanism initiates an adaptive response similar to that triggered by transient ROS increases generated from the mitochondria.

Our findings support and broaden the emerging hypothesis that directed ROS generation, e.g., in response to specific stimuli or in particular subcellular locations, acts as a homeostatic signal that can have substantial benefits ([@bib30]; [@bib88]; [@bib70]). The mitochondria generate ROS as a by-product of oxidative phosphorylation, and thereby integrate the rate of metabolism with the animal's physiology. The beneficial effects of low-dose mitochondrial ROS on healthspan and lifespan arise from a hormetic adaptation to mild stress ([@bib30]; [@bib88]; [@bib70]). Similarly, it was shown recently that ROS production arising from perturbed ER redox homeostasis leads to a protective response that increases lifespan ([@bib35]). In each of these examples, mutants that lack the capacity to detoxify ROS (e.g. *skn-1(-)* and *sek-1(-)*) exhibit a shortening of lifespan, indicating that these ROS are detrimental in the absence of this response ([@bib81]; [@bib97]; [@bib80]; [@bib37]; [@bib78]; [@bib35]). By contrast, ROS generated by the BLI-3 NADPH oxidase did not further shorten the lifespan of *memo-1* mutant animals that lack the oxidative stress response genes *skn-1* and *sek-1* ([Figure 2A,B and G](#fig2){ref-type="fig"}). This suggests that the health benefits from NADPH oxidase-generated ROS are initiated by a signaling cascade in the absence of an adaptive stress response to damage, and therefore arise from a ROS signal per se.

A variety of extracellular and intracellular stimuli induce NADPH oxidase activation ([@bib49]). The roles of these enzymes in innate immunity are well-documented, and in *C. elegans* the NADPH oxidase BLI-3 produces ROS in response to pathogen infection, leading in turn to activation of NSY-1/ASK1/MAPKKK, SEK-1/MAPKK, PMK-1/p38 MAPK and SKN-1/Nrf ([@bib33]). BLI-3 and p38/SKN-1 are also activated by stress from sodium arsenite ([@bib35]). Importantly, interactions with various cell surface receptors results in NADPH oxidase activation. These include not only receptors involved in immunity signaling but also growth factor receptors ([@bib49]), with the best-described paradigm being the dependence of EGFR signaling on ROS that are produced by NADPH oxidase in response to EGF binding ([@bib94]). Our results suggest that all of these signaling events have the potential to impact upon SKN-1/Nrf, and potentially other ROS-responsive mechanisms that influence longevity. Now that we have established MEMO as a regulator of NADPH oxidase, it will be of interest in the future to investigate whether MEMO might be involved in controlling these signaling pathways.

Another exciting subject for future study will be to elucidate how MEMO-1-responsive ROS signals generated by NADPH oxidase act upon the p38 MAPK pathway. Interestingly, NSY-1 and its mammalian homolog ASK-1 are each regulated for activation through cysteine oxidation for activation ([@bib63]; [@bib35]), suggesting that this kinase may respond directly to BLI-3-generated ROS. Furthermore, signaling from NADPH oxidases has been shown to activate Nrf2-mediated transcription in mammals ([@bib86]; [@bib29]; [@bib10]; [@bib85]; [@bib83]; [@bib65]; [@bib35]); and RhoA GTPase activity has been linked to NADPH oxidase activation and p38 MAPK signaling ([@bib46]). Interestingly, inducing endoplasmic reticulum (ER) stress in HUVEC cultures leads to active RhoA translocation to the ER membrane, resulting in Nox4-dependent ROS generation at this location ([@bib99]). Taken together, these findings show a possible conservation of an overall signaling pathway through which mechanisms controlled by MEMO and RhoA activate NADPH oxidase-mediated ROS signaling to act on p38 MAPK and SKN-1/Nrf.

Breast cancer cells that lack Memo1 fail to migrate upon stimulation with growth factors ([@bib56]). Moreover, it was shown that Memo1 is required for the localization of GTP-bound RhoA at the plasma membrane ([@bib103]), an essential step in the process of cell migration. Forcing RhoA to be constitutively membrane-bound rescued the migration phenotype of cells lacking Memo1 ([@bib103]), suggesting a conserved and biologically relevant interaction between Memo1 and RhoA. We have tried a similar experiment in *C. elegans* to determine whether adult-specific expression of constitutively active RHO-1(G14V) could by-pass *memo-1 *f*unction*. We predicted that adult-specific overexpression of RHO-1(G14V) would activate BLI-3/NADPH oxidase leading to an increased lifespan. Unfortunately, overexpression of the constitutively active RHO-1(G14V) GTPase specifically during adulthood causes lethality within 2-4 days (data not shown; \[[@bib57]\]). The activity of NADPH oxidase has been shown to be essential during cell migration ([@bib91]; [@bib38]). Interestingly, Memo1 has been linked to NADPH oxidase activity in breast cancer cells ([@bib55]), however the exact mechanism underlying these results, as well as a role for RhoA, has not been established and is likely to be context-dependent.

Memo1 is a highly conserved protein with homologues found in bacteria through vertebrates ([@bib79]). The most conserved portion of Memo1 is the domain that has three conserved histidine residues. These three histidines, which are present in the *C. elegans* protein, are required for copper binding, and for Memo1's copper-reducing activity in breast cancer cells ([@bib55]). One speculative but exciting possibility for a future study would be to investigate whether MEMO-1 might sense ROS through this metal-binding domain, and whether this might provide a feedback mechanism that regulates this ROS-generating pathway.

In the future, it will be important to understand how directed NADPH oxidase activity promotes healthy aging in mammals. In mice, loss of NADPH oxidase activity accelerated aging ([@bib12]; [@bib51]). By contrast, chronic ROS generation by NADPH oxidase has been suggested to promote age-dependent diseases ([@bib47]), showing that NADPH oxidase and the generated ROS need to be tightly regulated. Our data reveal that transient or low NADPH oxidase-generated ROS act as a signal to re-establish homeostasis during aging, and imply that signals that affect NADPH oxidase activity can also influence longevity. An exciting aspect of our findings is that NADPH oxidase activity is inducible and controllable, suggesting a novel target for therapeutics to promote healthy aging.

Materials and methods {#s4}
=====================

Strains {#s4-1}
-------

*Caenorhabditis elegans* strains were maintained on NGM plates and OP50 *Escherichia coli* bacteria at 20°C as described in [@bib9]. The wild-type strain was N2 Bristol ([@bib9]). Mutant strains used are described in Wormbase ([www.wormbase.org](http://www.wormbase.org)): LGII: *let-23(n1045), rrf-3(pk1426)*; LGIII: *daf-2(e1368)*; LGIV: *skn-1(zu67, zu129)*; LGIV: *isp-1(qm150)*; LGV: *memo-1(gk345)*; LGX: *sek-1(km4)*. Transgenic strains: CL2166 *dvIs19* \[P*gst-4*::GFP; pRF4 *rol-6(su1006gf)*\] ([@bib53]), CF702 *muIs32* \[P*mec-7*::GFP; *lin-15*(+)\] II ([@bib11]), LD001 *ldIs007* \[P*skn-1*::SKN-1b/c::GFP; pRF4 *rol-6(su1006gf)*\] ([@bib3]), LD1171 *ldIs003* \[P*gcs-1*::GFP; pRF4 *rol-6(su1006gf)*\] ([@bib96]), LD1252 *ldIs020* \[P*skn-1*::SKN-1S393::GFP\]; ([@bib95]), *ldEx102* \[*rol-6(su1006)*\] ([@bib19]), *jrIs1*\[P*rpl-17*::HyPer\] ([@bib5]), SJ4100 *zcIs13* \[P*hsp-6*::GFP\]V ([@bib102]), TJ356 *zIs356* \[P*daf-16*::DAF-16a/b::GFP; pRF4 *rol-6(su1006gf)*\] ([@bib31]), QZ16 *muIs32* \[P*mec-7*::GFP; *lin-15*(+)\] II; *memo-1(gk345)* V, QZ25 *muIs32* \[P*mec-7*::GFP; *lin-15*(+)\] II; *eri-1(mg366)* IV; *lin-15b(n744)* X, QZ50 *jxEx8* \[P*memo-1*::GFP; Pmyo-3::RFP\].

*memo-1(gk345)* knock out mutant {#s4-2}
--------------------------------

*memo-1(gk345)* mutants were obtained from *Caenorhabditis* Genetics Center (CGC; Strain VC794) and were outcrossed eight times against wild type (N2). The *gk345* deletion in *memo-1* deletes the transcription initiation ATG from isoform A (C37C3.8a), but not isoform B (C37C3.8b). The *gk345* deletion causes a frame shift leading to an early stop codon in isoform B (C37C3.8b), which might express a truncated peptide of 30 amino acids. However, only the first 18 out of these 30 amino acids are shared with the wild-type MEMO-1 protein. Furthermore, the *gk345* deletion covers 2 out the five important amino acids of the copper-binding/enzymatic binding site and therefore any possible splice variant might not be functional. This suggests that *gk345* deletion could potentially be a null allele of *memo-1*.

Construction of transgenic lines {#s4-3}
--------------------------------

Construction of transcriptional fusion of *memo-1* promoter with GFP (*jxEx8* \[P*memo-1*::GFP\]). The cis regulatory regions of *memo-1*/C37C3.8 were amplified by PCR from cosmid C37C3 (Accession number U64857) using memo-GFP fusion primers as described in [@bib32]. PCR for 5' cis region of *memo-1* (PCR1): Forward primer (memo-GFP-5for) and reverse primer (memo-GFP-5rev-int) that specifically recognizes the 5' end of the C37C3.8 locus are used to amplify the 5' cis region of the *memo-1* gene and the first 48 amino acids of the b isoform of the gene (3.5 kb). PCR for 3' cis region of *memo-1* (PCR2): Forward primer (memo-GFP-3for:) and a reverse primer (memo-GFP-3rev-int) that specifically recognizes the 3' end of the C37C3.8 locus are used to amplify the 3' untranslated region (UTR) and the 3' cis region of the *memo-1* gene (264 bp). PCR3: The green fluorescent protein (GFP) open reading frame (1.4 kb) was amplified from L3691 plasmid (pPD117.01 Fire Lab Vector Kit Documentation 1997. ([www.addgene.org](http://www.addgene.org))) using fusion primers (gfp-[memo]{.ul}-for and gfp-[memo]{.ul}-rev). The PCR product from PCR3 was then fused to the 5' cis memo PCR product from PCR1, as well as to the 3' cis memo PCR product from PCR2 in a third round of PCR reactions. The resulting two fragments from the third round of PCR reactions are then fused into one final PCR product (P*memo-1*::GFP) in a fourth round of reaction. Primer sequences are found in [Supplementary file 3](#SD4-data){ref-type="supplementary-material"}). This fused PCR fragment of P*memo-1*::GFP (50 ng/µl together with 100 ng/µl of P*myo-3*::RFP) was injected into wild-type (N2) worms and three transgenic \[P*memo-1*::GFP\] lines were obtained, of which one was chosen for analysis (QZ50 *jxEx8* \[P*memo-1*::GFP; Pmyo-3::RFP\]).

Generation of transgenic lines {#s4-4}
------------------------------

Overexpression of MEMO::GFP: 35 ng/µl *tag-253* fosmid (WRM0639B_H07(pRedFlp-Hgr)(tag-253\[30783\]::S0001_pR6K_Amp_2xTY1ce_EGFP_FRT_rpsl_neo_FRT_3xFlag)dFRT::unc-119-Nat from <https://transgeneome.mpi-cbg.de/transgeneomics/index.html>) together with 100 ng/µl pRF4 *rol-6(su1006gf)* was injected into wild-type (N2) worms and four transgenic *ldEx112-6* \[MEMOfosmid::GFP\] lines were obtained, of which one was chosen for picture analysis and CoIP (*ldEx112* \[MEMOfosmid::GFP; *rol-6(su1006gf)*\]).

Overexpression of BLI-3: 5 ng/µl of plasmid pHM363 \[BLI-3\] ([@bib62]) together with 100 ng/µl pRF4 *rol-6(su1006gf)* was injected into wild-type (N2) worms and one transgenic *ldEx117* \[BLI-3\] line was obtained for analysis.

Triple transgenic overexpression (BLI-3, DOXA-1, TSP-15): 5 ng/µl of plasmid pHM363 \[BLI-3\] ([@bib62]), 5 ng/µl of plasmid pHM327 \[DOXA-1::Venus\] ([@bib62]), 5 ng/µl of plasmid pHM106 \[HisXp::TSP-15\] ([@bib62]), together with 100 ng/µl pRF4 *rol-6(su1006gf)* was injected into wild-type (N2) worms and one transgenic *ldEx118* \[BLI-3, DOXA-1, TSP-15\] lines were obtained for analysis.

Knockdown by RNA interference {#s4-5}
-----------------------------

RNAi\#1 clone is from Vidal RNAi library ([@bib75]) and RNAi\#2 clone is from Ahringer RNAi library ([@bib21]; [@bib40]). RNAi bacteria cultures were grown overnight in LB with carbenicillin \[100 µg/ml\] and tetracycline \[12.5 µg/ml\], diluted to an OD600 of 1, and induced with 1 mM IPTG and spread onto NGM plates containing tetracycline \[12.5 µg/ml\] and ampicillin \[50 µg/ml\]. For empty RNAi vector (EV) plasmid pL4440 was used as control. For double RNAi: bacterial cultures were grown separately and then mixed in a 1:1 ratio, except for combinations with *bli-3(RNAi)*. As reported in [@bib13], a 1:10 ratio for *bli-3* to other bacteria clone for the double RNAi treatment was used because of the strong *bli-3* blistering phenotype.

Measuring total ROS levels with fluorescent probe {#s4-6}
-------------------------------------------------

The total level of ROS were measured by using either a small diffusible fluorescent probe (chloromethyl derivative; CM-H~2~DCFDA; Life Technologies) or with the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Life Technologies) with a protocol adapted from [@bib84]. Briefly, wild-type eggs were hatched on empty vector (EV) or *memo-1(RNAi)* food and harvested for assay at larval stage 4 (L4). More than 1000 L4 animals per conditions were harvested into 96-well plates, incubated in 50 µM CM-H~2~DCFDA for 1 hr and the fluorescent intensity was measured with an excitation wavelength of 485 nm and a 520 nm emission filter. Detection of ROS by Amplex Red was performed according to manufacturer's instructions and fluorescence was measured with an excitation wavelength of 530 nm and a 590 nm emission filter. Animals were lysed and protein levels were determined using BCA assay (Pierce). The fluorescent intensity was normalized to protein levels and is indicated relative to control.

Measuring endogenous hydrogen peroxide levels with transgenic HyPer worms {#s4-7}
-------------------------------------------------------------------------

To measure endogenous hydrogen peroxide levels, transgenic *jrIs1*\[P*rpl-17*::HyPer\] worms expressing a HYPER-probe were used as described in [@bib5]. Transgenic *jrIs1*\[P*rpl-17*::HyPer\] animals were treated with RNAi and about 1000 L4 worms were harvested in 96 microtiter well plates. An excitation wavelength of either 490 nm or 405 nm was used to measure oxidized or reduced HyPer probe fluorescence respectively with an emission filter of 535 nm. The animals were harvested and protein levels were determined using BCA assay (Pierce). The fluorescence intensity was normalized to protein and the ratio of oxidized/reduced HyPer levels was calculated using the 405 nm fluorescence as a numerator and the 490 nm fluorescence as the denominator as described in [@bib5].

Antioxidant treatment {#s4-8}
---------------------

For GSH treatment, NGM plates containing 5 mM GSH (Sigma) were poured and allowed to dry. The respective *E.coli* food source was added to each plate and once dry, animals (young adult) were added to the plate and allowed to lay eggs. Nematodes grew for one generation on these plates prior to ROS analysis or GFP scoring. Inhibition of BLI-3 by DPI (Diphenyleneiodonium chloride, Sigma) was performed by treating animals with 80 µM of the compound in M9 solution for 15 min prior to analysis. Removal of mitoROS by the mitochondrial-targeted superoxide scavenger Mito-Tempo (Sigma) occurred by exposing animals to 250 µM of the antioxidant for 2 hr in M9 solution prior to ROS determination.

Measuring mitoROS {#s4-9}
-----------------

Wild-type eggs were hatched on the respective *E. coli* food source and harvested for mitoROS analysis at larval stage 4 (L4). As a positive control, wild-type animals were treated with 3 mM Anitmycin A for 2 hr, by top-coating the culturing plates containing the L4 and bacterial food. Approximately 1000 L4 animals per condition were washed and added into each well of a 96-well plate, incubated in 50 µM Mitotracker Red CM-H~2~XRos (Life Technologies) for 2 hr in the dark on a shaker and the fluorescent intensity was measured with an excitation wavelength of 570 nm and a 610 nm emission filter. Subsequently, animals were lysed and the total protein levels were determined using the BCA assay (Pierce). The level of fluorescence was normalized to protein levels and is expressed relative to control.

Lifespan assays {#s4-10}
---------------

Adult lifespan was determined either with or without 5-Fluoro-2'deoxyuridine (FUdR), a DNA synthesis inhibitor that blocks progeny production and thus prevents overcrowding. For non-FUdR lifespan assays: About 100 L4 worms per strain were picked on NGM plates containing OP50 bacteria. Worms were transferred every day or every other day on fresh NGM OP50 plates until progeny production ceased as described in [@bib43], [@bib2]. For FUdR lifespan assays: About 100 L4 worms per strain were picked on NGM plates containing OP50 bacteria. The next day, worms (day-1-adults) were transferred onto either NGM plates containing 400 µM FUdR and OP50 bacteria or RNAi bacteria (or plates that also contained 5 mM GSH, or OP50 that were heat-killed by 1 hr of incubation at 75°C before seeding). Animals were scored every day or every other day. All lifespans were plotted with L4 as time-point = 0. Animals were scored as dead animals if they failed to respond to prodding. Exploded or bagged animals and animals that ran off the plate were excluded from the statistics. The estimates of survival functions were calculated using the product-limit (Kaplan-Meier) method. The log-rank (Mantel-Cox) method was used to test the null hypothesis and calculate *P* values (JMP software v.9.0.2.).

Oxidative stress assays {#s4-11}
-----------------------

For arsenite stress tolerance assay: about 50 L4 worms per strain/ condition were picked onto fresh OP50 plates. The next day, 10--12 day-one worms were picked into 24 well plates containing 50 µl physiological M9 Buffer in quadruplicates for each strain and condition (four wells). Then when all worms were set up, 1 mL M9 buffer with either a final concentration of 5 mM or 10 mM sodium arsenite (Sigma-Aldrich) was added to three wells per strain and condition. In the remaining well only 1 mL M9 buffer was added as a control. The survival was scored every hour until all died. Exploded animals were excluded from the statistics. For *tert*-Butyl hydroperoxide (*t*-BOOH) stress tolerance assay: about 80 L4 worms per strain/ condition were picked onto fresh OP50 plates. Three days later, 20 day-three worms were picked onto NGM plates containing 15.4 mM *t*-BOOH (Sigma-Aldrich). Because worms try to avoid the *t*-BOOH, they leave the plate. For the first two hours worms were continually repositioned into the middle of the plate until they ceased crawling. Survival was scored every hour. Exploded animals or animals damaged from moving were censored from the statistics. For both arsenite and *t*-BOOH the estimates of survival functions were calculated using the product-limit (Kaplan-Meier) method. The log-rank (Mantel-Cox) method was used to test the null hypothesis and calculate *P* values (JMP software v.9.0.2.). Both oxidative stress tolerance assays are described in more detail at Bio-protocol ([@bib18]).

Quantitative real-time polymerase chain reaction (qRT-PCR) assays {#s4-12}
-----------------------------------------------------------------

RNA was isolated with Trizol (TRI REAGENT Sigma), DNAse-treated, and cleaned over a column (RNA Clean and Concentrator ZYMO Research). First-strand cDNA was synthesized in duplicate from each sample (Invitogen SuperScript III). SYBR green was used to perform qRT-PCR (ABI 7900). For each primer set, a standard curve from genomic DNA accompanied the duplicate cDNA samples ([@bib24]). mRNA levels relative to N2 control were determined by normalizing to the number of worms and the geometric mean of three reference genes (*cdc-42, pmp-3,* and Y45F10D.4; \[[@bib34]\]). At least two biological replicates were examined for each sample. For statistical analysis, one sample *t*-test, two-tailed, hypothetical mean of 1 was used for comparison using Prism 6.0 software (GraphPad).

Scoring of transgenic promoter driven GFP or SKN-1::GFP nuclear localization {#s4-13}
----------------------------------------------------------------------------

For each assay, two investigators scored transgenic animals blindly after mounting on slides or with stereomicroscope essentially as described in [@bib73]. P*gcs-1*::GFP ([Figure 1I](#fig1){ref-type="fig"}) and P*gst-4*::GFP ([Figure 1G--H](#fig1){ref-type="fig"}, [3I](#fig3){ref-type="fig"}, [4C](#fig4){ref-type="fig"} and [5A](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}): At the L4 stage, *ldIs003* \[P*gcs-1*::GFP\] transgenic animals were mounted on slides and GFP fluorescence in the intestine was scored using Zeiss AxioSKOP2 microscope at 40x as described in [@bib96]. None: no GFP in intestine. Low: only anterior or posterior intestine with GFP. Medium: both anterior and posterior intestine with GFP but no GFP in the middle of the intestine. High: GFP throughout the intestine. *P* values were determined by Chi^2^ test.

P*gst-4*::GFP: At the first day of adulthood stage, transgenic *dvIs19* \[P*gst-4*::GFP\] ([@bib53]) animals were scored using stereoscope described in [@bib96]. None: no GFP in intestine. Low: only weak anterior or posterior intestine with GFP. Medium: both anterior and posterior intestine with strong GFP but no or weak GFP in the middle of the intestine. High: GFP throughout the intestine. *P* values were determined by Chi^2^ test. SKN-1::GFP nuclearlocalisation assay ([Figure 2D](#fig2){ref-type="fig"} and [4H](#fig4){ref-type="fig"}): Transgenic *ldIs007* \[P*skn-1*::SKN-1b/c::GFP\] ([@bib3]) L4 animals were mounted on slides and intestinal GFP scored as described in [@bib73] by using a Zeiss AxioSKOP2 microscope. none = no GFP observed in intestinal nuclei; low = some intestinal nuclei show GFP; medium = more than half of the intestinal nuclei show GFP; high = all intestinal nuclei show GFP. SKN-1::GFP is constitutively expressed in ASI neurons ([@bib3]) and we did not observe any noticeable change of SKN-1::GFP expression in ASI upon *memo-1* knockdown. *P* values were determined by Chi^2^ test using Prism 6.0 software (GraphPad).

Co-immunoprecipitation and immunoblotting {#s4-14}
-----------------------------------------

Approximately 5000 mixed-stage nematodes were sonicated in IP buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 2 mM EDTA and protease inhibitor) and kept on ice for 30 min before being centrifuged for 20 min at 13,000x g. The supernatant was pre-cleared with 50 µl slurry of Protein-G beads for 30 min at 4°C, centrifuged for 5 min at 2000 x g and the beads were removed. The supernatant (1 mg) was incubated with 2 μg of antibody overnight at 4°C. The following day, 50 μl slurry of Protein G beads was added to the lysate for 2 hr at 4°C after which the beads were washed three times in IP buffer and eluted in 2 x sample buffer (+2ME). SDS-page was performed with 10% Bis-Tris gels (Invitrogen) and proteins were transferred to nitrocellulose membranes (Pierce). Western blot analysis was performed under standard conditions with antibodies against GFP, RHO-1 (gift from A. Sugimoto), Tubulin (Cell signal Tech.), BLI-3 (gift from E. Mekada), and Phospho-p38 (Cell signal Tech.). HRP-conjugated rabbit anti-mouse and goat anti-rabbit secondary antibodies were purchased from Sigma and proteins were detected by enhanced chemiluminescence (Pierce). Quantification of protein levels was determined using ImageJ software and normalized to loading control.
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Thank you for submitting your article \"NADPH-oxidase-mediated redox signaling promotes oxidative stress resistance and longevity through Memo\" for consideration by *eLife*. Your article has been favorably evaluated by Tony Hunter (Senior Editor) and three reviewers, one of whom, Andrew Dillin (Reviewer \#1), is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary of work presented:

In this body of work the authors begin to explore how an interactor in the ErbB-2 tyrosine kinase pathway might contribute to aging in the nematode *C. elegans*. The closest ortholog of the mediator of ErbB2-driven cell motility factor, *memo-1*, results in increased lifespan when knocked down or mutated. This appears independent of dietary intake, insulin/IGF1 pathway or germline mediated responses. The interaction with the mitochondrial ETC pathway is sparsely explored and detailed more below.

Transcript analysis indicates that several antioxidant genes are induced by *memo-1* RNAi and lead to the hypothesis that *skn-1* might play a role in the *memo-1* mediated lifespan response. Genetic interaction studies and nuclear localization of *skn-1* support this hypothesis. Furthermore, ROS levels using 3 different sensors all indicate that ROS levels are increased. GSH treatment also blocks *memo-1* (RNAi) lifespan. However, the authors then go on to interrogate whether the ROS levels originate from mitochondria using mitotracker red and MitoTempo, both of which provide negative results without positive controls.

With a lack of correlation of ROS from mitochondria, the authors speculate that ROS is generated from another source and hypothesize that NAPDPH oxidase could be the culprit. Genetic studies of *bli-3* (NADPH oxidase) RNAi confirms their hypothesis in test of ROS levels and longevity. Importantly, *bli-3* overexpression increases ROS and increases lifespan.

Understanding how *bli-3* is regulated by *memo-1*, the authors query orthologes of known mammalian interactors of *memo-1* in a screen and uncover that loss of rho mirrors the effects seen with *bli-3* (although overexpression studies of rho are not performed).

While all reviewers remain enthusiastic about this body of work, a summary of additional experiments to strengthen the claims and interpretation of the results is provided:

1\) Because of the role of this pathway in innate immunity, the authors need to explore if the lifespan effects are due to bacterial infection/interaction. It is suggested to perform the lifespan extending experiments on dead bacteria (*memo-1* loss and *bli-3* overexertion).

2\) The involvement of mitochondrial produced ROS is not well controlled and we suggest that positive controls in the measurements are needed. *isp-1* mutant animals are documented to have increased ROS and are a good place to start.

3\) The involvement of the ETC longevity pathway is not explored and it is suggested to test *bli-3* RNAI on cco-1(RNAi) treated animals or *isp-1* mutant animals for lifespan extension. The same is true for *memo-1* loss.

4\) The closing experiments involving rho are not fully executed and do not fully test the model proposed. Does loss of rho block the ROS accumulation in *memo-1*(-) animals? Does loss of rho specifically reduce the lifespan of *memo-1*(-) or *bli-3*(o/e) animals? Does overexertion of rho extend lifespan, and is this *bli-3* dependent?

Finally, the title needs to include *C. elegans*.

10.7554/eLife.19493.019

Author response

*\[...\] While all reviewers remain enthusiastic about this body of work, a summary of additional experiments to strengthen the claims and interpretation of the results is provided:*

*1) Because of the role of this pathway in innate immunity, the authors need to explore if the lifespan effects are due to bacterial infection/interaction. It is suggested to perform the lifespan extending experiments on dead bacteria (memo-1 loss and bli-3 overexertion).*

We thank the reviewer for this suggestion. We investigated whether *memo-1* mutants live longer when fed heat-killed OP50, and included the findings in the text:

"Since *sek-1* and *skn-1* are important for the defense against pathogenic bacteria (Hoeven et al. 2011), and bacterial proliferation in the *C. elegans'* intestine contributes to death of the animal (Garigan et al. 2002), we investigated the lifespan of *memo-1* mutants on heat-killed bacteria. We found that *memo-1* mutants remain long-lived compared to wild type ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"})."

*2) The involvement of mitochondrial produced ROS is not well controlled and we suggest that positive controls in the measurements are needed. isp-1 mutant animals are documented to have increased ROS and are a good place to start.*

We thank the reviewer for pointing this out. We have repeated mitochondrial ROS assays and as a positive control used Antimycin A, which binds cytochrome c reductase and thereby disrupts the proton gradient across the inner mitochondrial membrane, which results in the formation of mitochondrial ROS. For 2 of the 5 biological independent trials, we split our animal populations in half and used the corresponding half to measure hydrogen peroxide in the supernatant with Amplex Red, in parallel to the mitochondrial ROS measurements with MitoTracker Red CMXRos, as we did in the previous experiments. Antimycin A increased ROS levels, as measured with both MitoTracker Red and Amplex Red. Mutants that lack *memo-1* showed an almost 2-fold increase in ROS measured with Amplex Red, but showed no significant difference in mitochondrial ROS compared to wild type measured with MitoTracker Red. This argues that the mitochondria are not the source of ROS in animals that lack *memo-1*. We included these data in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.

*3) The involvement of the ETC longevity pathway is not explored and it is suggested to test bli-3 RNAI on cco-1(RNAi) treated animals or isp-1 mutant animals for lifespan extension. The same is true for memo-1 loss.*

As suggested, we have performed the lifespan of *isp-1* mutants treated with *bli-3* RNAi and *memo-1* RNAi. The *bli-3(RNAi)* did not suppress and *memo-1(RNAi)* was additive to the longevity of *isp-1* mutants, suggesting an independent or parallel pathway to the ETC longevity pathway ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). We included this in the text:

"Moreover, the longevity of *memo-1(RNAi)* treated animals was additive to the longevity of electron transport chain mitochondrial mutant *isp-1(qm150)* ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"})."

"Next we examined the role of BLI-3 in the *memo-1(-)*-induced phenotype. Adult-specific knockdown of *bli-3* did not alter wild-type lifespan or longevity resulting from dietary restriction, reduced insulin/IGF-1 signaling or reduced mitochondrial electron transport chain activity ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}), but completely eliminated the *memo-1(-)* longevity phenotype ([Figure 4G](#fig4){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"})."

*4) The closing experiments involving rho are not fully executed and do not fully test the model proposed. Does loss of rho block the ROS accumulation in memo-1(-) animals?*

Knockdown of *rho-1* in *memo-1(-)* mutants partially suppressed the ROS accumulation in *memo-1(-)* mutants ([Figure 5C](#fig5){ref-type="fig"}). The partial suppression might be because RNAi does not cause a complete loss of expression, and because wild type animals fed *rho-1* RNAi exhibited higher ROS levels in 2 out of 3 trials. This suggests that *rho-1* knockdown may, through an unknown mechanism, increase ROS on its own.

*Does loss of rho specifically reduce the lifespan of memo-1(-) or bli-3(o/e) animals?*

In two independent trials, adulthood *rho-1(RNAi)* completely suppressed *memo-1(-)* mutant longevity ([Figure 5D](#fig5){ref-type="fig"}, [Supplementary file 1](#SD2-data){ref-type="supplementary-material"})Furthermore, adulthood *rho-1(RNAi)* partially suppressed longevity of BLI-3 overexpressing animals (1 independent trial; [Figure 5E](#fig5){ref-type="fig"}, [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). This indicates that *rho-1* makes a major contribution to *bli-3*-mediated longevity, and supports our models. The partial dependence could be due to the fact that *rho-1* function is unlikely to be completely eliminated by *rho-1* RNAi treatment during adulthood. RHO-1 has many important functions, and null mutants of *rho-1* are embryonic lethal. To bypass *rho-1* requirements during development, Rachel McMullan and Stephen Nurrish have generated transgenic animals that can drive an inhibitor of endogenous Rho (C3 transferase) by an inducible heat-shock promotor. Unfortunately, adult-specific expression this Rho inhibitor caused lethality within 2-3 days ([@bib57]). Therefore, we were not able to investigate a complete loss of *rho-1* function during adulthood.

We incorporated these data and added the following sentences in the manuscript.

"Knocking down *rho-1* in *memo-1(gk345)* mutants partially suppressed the *memo-1(-)* ROS induction ([Figure 5C](#fig5){ref-type="fig"}). Moreover, adult-specific knockdown of *rho-1* completely suppressed the longevity of *memo-1(gk345),* and partially blocked the lifespan extension from BLI-3 overexpression ([Figure 5D, 5E](#fig5){ref-type="fig"} and [Supplementary file 1](#SD2-data){ref-type="supplementary-material"})."

*Does overexertion of rho extend lifespan, and is this bli-3 dependent?*

Overexpression of the constitutively active RHO-1(G14V) GTPase specifically during adulthood causes lethality within 2-4 days (McMullan & Nurrish 2011). Dr. Stephen Nurrish kindly gave us these transgenic animals (QT54 *nzIs1* \[P*hsp-16.2*::RHO-1(G14V)\]), in which RHO-1(G14V) expression is driven by a heat-shock promoter. We tried very hard to establish conditions whereby weaker activation of the heat-shock promoter (e.g. at 25^o^C) would lead to lower levels of RHO-1(G14V) expression that might not be toxic, but even under these conditions RHO-1(G14V) overexpression during adulthood shortened lifespan (not shown). This result is not surprising given the many functions of RHO-1 in cellular architecture and signaling. We hope that the reviewer will agree that this result does not contradict our models, particularly in light of our other data supporting the involvement of RHO-1 in BLI-3-mediated longevity.

*Finally, the title needs to include C. elegans.*

*C. elegans* is now included in the title.

[^1]: These authors contributed equally to this work.
